Latest Breaking News On - Hospital cellular immunotherapy program - Page 1 : comparemela.com

FDA: CAR T-Cell Therapies May Increase Risk for Rare Secondary Cancers

Twenty-five reports of rare blood cancers in patients who had received CAR T-cell therapy prompted agency's warning

United statesCarly kemplerMatthew frigaultJohnson carvyktiHospital cellular immunotherapy programBristol myers squibbGilead sciencesDrug administrationHealthday newsGilead science kite pharma

FDA says cancer treatment CAR-T therapy may increase risk of cancer

Does CAR-T therapy increase the risk of cancer? The FDA said the cancer treatment may raise the risk of secondary cancers.

United statesJohnson carvyktiHemant murthySloan ketteringMarcela mausSaad usmaniMatthew frigaultBruce levineCarly kemplerGilead sciencesUniversity of pennsylvaniaCellular immunotherapy program at massachusettsBristol myers squibbDrug administrationHarvard medical schoolHospital cellular immunotherapy program

FDA Adds Boxed Warning to CAR-T Therapies

The FDA told several drugmakers to add a boxed warning to a type of cancer treatment called CAR-T therapy, saying it might actually cause cancer.

United statesCarly kemplerHemant murthyMatthew frigaultJohnson carvyktiSloan ketteringSaad usmaniGilead sciencesHospital cellular immunotherapy programBristol myers squibbDrug administrationHealthday newsMyers squibbGilead science kite pharmaMayo clinicMemorial sloan kettering

FDA warns of rare secondary cancer risk with CAR-T therapies

FDA warns of rare secondary cancer risk with CAR-T therapies
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesCarly kemplerJohnson carvyktiMatthew frigaultNational cancer instituteBristol myers squibbHospital cellular immunotherapy programDrug administrationGilead sciencesGilead science kite pharma